Prescription drug · ANDA
Acyclovir NDC 72241-026
Acyclovir 400 mg/1 · Tablet · Oral · Modavar Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72241-026-05 | 72241002605 | 100 TABLET in 1 BOTTLE (72241-026-05)Marketed from Aug 18, 2021 | |
| 72241-026-10 | 72241002610 | 500 TABLET in 1 BOTTLE (72241-026-10)Marketed from Aug 18, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acyclovir
- Generic name (nonproprietary)
- acyclovir
- Active ingredients
- Acyclovir — 400 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Modavar Pharmaceuticals LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202168
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 72241-026_ea578b6a-2897-45b9-8757-a2d9caf34459SPL ID ea578b6a-2897-45b9-8757-a2d9caf34459SPL set ID 8de9c4f3-b800-4419-a063-8b62a0cba0faRxCUI 197311, 197313UNII X4HES1O11FUPC 0372241027109, 0372241026102, 0372241027055
- Pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472241002605followed by a unit qualifier and the quantityPackage 72241-0026-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Herpes Zoster Infections: Acyclovir Tablet is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes: Acyclovir Tablet is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox:Acyclovir Tablet is indicated for the treatment of chickenpox (varicella).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 202168
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acyclovir | Acyclovir 800 mg/1 | TabletOral | Cadila Pharmaceuticals Limited | 71209-006 |
| Acyclovir | Acyclovir 400 mg/1 | TabletOral | Cadila Pharmaceuticals Limited | 71209-005 |
| Acyclovir | Acyclovir 800 mg/1 | TabletOral | Modavar Pharmaceuticals LLC | 72241-027 |